Our data demonstrate that the efficacy of erwinase resides in its glutaminase activity in PI3K-altered cancer cells, as kidrolase, another L-asparaginase lacking a robust affinity to glutamine, fails to demonstrate any cytotoxic effect. This evidence concerns the gene GLS and cancer.